SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-004926
Filing Date
2020-01-24
Accepted
2020-01-24 18:34:11
Documents
1
Period of Report
2020-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7048
  Complete submission text file 0001209191-20-004926.txt   8470
Mailing Address C/O COLLAGENEX PHARMACEUTICALS, INC. 41 UNIVERSITY DRIVE NEWTOWN PA 18940
Business Address
Powell Andrew Kenneth William (Reporting) CIK: 0001304113 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38756 | Film No.: 20546741

Mailing Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037 (858) 750-4700
Synthorx, Inc. (Issuer) CIK: 0001609727 (see all company filings)

IRS No.: 464709185 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations